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ABSTRACT 
Objective: The purpose of this study was to design mucoadhesive gastro spheres of carvedilol targeting to upper GIT, and optimize it in terms of its 
entrapment efficiency and drug release. A 32
Methods: Mucoadhesive gastro spheres were prepared by Orifice-Ionic gelation method, in which drug is uniformly distributed in the polymer 
solution so drug can be loaded easily in the polymer.3
 full factorial design was employed to study the effect of independent variables like sodium alginate and 
sodium carboxyl methyl cellulose on entrapment efficiency and in vitro drug release.  
2
Results: FTIR, XRD and DSC analyses apparently did not indicate any interaction of the drug with the polymers. However, the drug content, drug 
entrapment efficiency and morphology of the gastro spheres were found to be influenced by the method of preparation, composition of gastro 
spheres as well as exposure to the cross linking agent. In vitro drug release study showed that drug release can be modified by varying drug to 
polymer ratio. The release rate was found to be decreased in accordance with the increase in the ratio of polymer used.  
 full factorial designs were used to study the effect of process variables on formulation 
characteristics by applying statistical analysis. 
Conclusion: From the study, we successfully developed carvedilol gastro spheres by using mucoadhesive polymer like SCMC and rate retardant 
sodium alginate polymer. 
Keywords: Carvedilol, Mucoadhesive, Gastro spheres, Factorial design 
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INTRODUCTION 
Drug delivery systems (DDS) that can precisely control the release 
rates or target drugs to a specific body site have an enormous 
impact upon the healthcare system. The oral route of drug 
administration is the most largely used and preferred means of drug 
delivery to the systemic circulation of the body. However, the drugs 
which are administered through oral route in the form of 
conventional dosage have limitations of their inability to limit and 
localize the system at gastrointestinal tract. Carrier technology offers 
an intelligent approach for drug delivery by coupling the drug to a 
carrier particle such as a microsphere, nanoparticles, etc., which 
modulates the release and absorption characteristics of the drug [1].  
Microspheres/micro particles constitute an important part of this 
particulate drug delivery system by virtue of their small size and 
efficient carrier characteristics. These delivery systems offer 
numerous advantages compared to conventional dosage forms, 
which include improved efficacy, reduced toxicity, improved patient 
compliance and convenience. Such systems often use 
macromolecules as carriers for the drugs [1].  
Multiparticulate delivery systems like gastro spheres are prepared 
to obtain prolonged or controlled drug delivery, to improve 
bioavailability or stability and to target the drug to specific sites. 
They can distribute in the GI tract homogeneously, thus maximizing 
drug absorption and reducing peak plasma fluctuations, minimizing 
the risk of local GI tract irritation and dose dumping, decreasing 
dosing frequency and increasing patient compliance, improving the 
safety and efficacy of the active ingredient [2].  
Gastro spheres are the particulate drug delivery systems which 
achieve the target of gastric retention by mainly two mechanisms, 
i.e.; buoyancy and bio-adhesion. Due to their small size and efficient 
carrier characteristics, gastro spheres constitute an important part 
through the particulate novel drug delivery system. The limitation of 
gastro spheres is due to their short residence time on the site of 
absorption, and it can be overcome by providing an intimate contact 
of the drug-delivery system with the absorbing membrane. This can 
be accomplished by coupling bio-adhesion characteristics to gastro 
spheres and developing mucoadhesive gastro spheres [3]. Extending 
the residence time with a dosage form at a particular site and 
controlling the release of drug from the dosage form are useful, 
especially for achieving controlled plasma level of the drug as well as 
improving bioavailability.  
Carvedilol is a non-selective α1, β1, β2-adrenergic antagonist used 
for the treatment of hypertension and stable angina pectoris. It also 
possesses antioxidant and anti-proliferating effects, which may 
enhance its ability to fight the deleterious effects of sympathetic 
nervous system activation in heart failure. Carvedilol is having poor 
water solubility (BCS class II) [4-6]. The formulation of a poorly 
soluble drug for oral delivery will be one of the biggest challenges. 
Carvedilol microspheres are reported to have good spherical 
geometry with prolongation of drug release at a constant and 
controlled rate. Carvedilol microcapsules have also been beneficial 
for increasing its bioavailability [7]. The present investigation 
relates to the development of mucoadhesive gastro spheres of 
Carvedilol, which will increase the gastric residence time and allow 
more of the drug to penetrate through the gastric mucus layer which 
may help to improve the bioavailability of carvedilol.  
MATERIALS AND METHODS 
Carvedilol was provided ex gratis by Alembic Pvt. Ltd, (Vadodara). 
Sodium alginate (Research Lab. Pvt. Ltd. Mumbai), sodium carboxy 
methyl cellulose (LobaChem. Pvt. Ltd. Mumbai), Calcium chloride 
(Research Lab. Pvt. Ltd. Mumbai). All other chemicals employed 
were of analytical grade.
Formulation of mucoadhesive gastro spheres 
  
Carvedilol-Sodium alginate gastro spheres containing sodium 
carboxyl methyl cellulose was prepared using calcium chloride 
(CaCl2) as cross-linking agent by ionic gelation method. Briefly, 
required amounts of sodium alginate and sodium carboxyl methyl 
cellulose were dissolved in distilled water (20 ml) using a magnetic 
stirrer for 30 min. Afterward, carvedilol was added to the mixture 
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solutions of sodium alginate and sodium carboxyl methyl cellulose 
for each formulation and mixed thoroughly using a magnetic stirrer 
(Remi Motors, India). The final sodium alginate-sodium 
carboxymethyl mixture cellulose solutions containing carvedilol 
were ultra-sonicated for five min for debubbling. The resulting 
dispersion was then added via a 21-gauge needle dropwise into 40 
ml of 10% (w/v) CaCl2 solutions. Added droplets were retained in 
the CaCl2 solutions for 15 min to complete the curing reaction and to 
produce rigid spherical gastro spheres. The gastro spheres were 
collected by decantation and washed two times with distilled water 
and dried at 37 ◦C for overnight. The dried gastro spheres were 
stored in a desiccator until used.  
Experimental design for optimization 
In order to obtain "optimized product," nine different formulations 
was generated using 32 factorial designs. The amount of sodium 
alginate (X1) and the amount of sodium carboxyl methyl cellulose 
(X2) were taken as independent formulation variables while % drug 
content (Y1), % entrapment efficiency (Y2) and % drug release at 12 
h (Y3) were considered as dependent or response variables. A 
statistical model incorporating interactive and polynomial terms 
was used to evaluate the responses. Design Expert (Version 7.0.0) 
software was used during the generation and evaluation of the 
statistical experimental design [9, 10]. The effects of independent 
variables were modeled using a quadratic mathematical equation 
generated by a 32 factorial design such as Y= b0+b1X1+ 
b2X2+b12X1X2+b11X12+b22X22. 
Where Y is the response; b0 is the intercept, and b1, b2, b12, b11; 
b22 are regression coefficients. X1 and X2 are individual effects; X12 
and X22 are quadratic effects; X1 X2 is the interaction effect. One-
way ANOVA was applied to estimate the significance of models 
(p<0.05). Individual response parameters were evaluated using the 
F test. The response surface plots were analyzed to reveal the effect 
of independent factors (amount of SCMC and sodium alginate) on 
the measured responses (% DC, % DEE and % DR). The details in the 
design are shown in table No.1 and
  
 2. 
Table 1: Selection of levels of independent variables 
Coded value Sodium alginate (mg) X1 Sodium carboxyl methyl cellulose (mg) X2 
-1 300 100 
0 400 200 
1 500 300 
*X1: amount of sodium alginate, X2: amount of sodium carboxyl methyl cellulose, mg: milligram 
 
Table 2: Design layout of composition of 32
Batch code 
 factorial batches of gastro spheres 
Code value Actual value Drug (mg) 
SA SCMC SA (mg) SCMC (mg) 
F1 -1 -1 300 100 400 
F2 -1 0 300 200 400 
F3 -1 +1 300 300 400 
F4 0 -1 400 100 400 
F5 0 0 400 200 400 
F6 0 +1 400 300 400 
F7 +1 -1 500 100 400 
F8 +1 0 500 200 400 
F9 +1 +1 500 300 400 
 
Characterization of gastro spheres 
Drug entrapment efficiency 
Gastro spheres equivalent to 5 mg of carvedilol was taken and was 
crushed using pestle and mortar. The crushed powders of drug 
containing gastro spheres were placed in 25 ml of 0.1N HCl and kept 
for 24 h with occasionally shaking at 37+/-0.5 ◦C. After the 
stipulated time, the mixture was stirred at 500 rpm for 20 min using 
a magnetic stirrer (Remi Motors, India). The polymer debris formed 
after the disintegration of gastro spheres was removed filtering 
through Whatman® filter paper (No. 40). The drug content in the 
filtrate was determined using a UV-VIS spectrophotometer 
(LabIndia) at 280 nm against appropriate blank. The drug 
entrapment efficiency was calculated using the following formula. 
DEE (%) = (
Actual
Theoretical
 Drug Content) × 100  
Particle sizes analysis 
The particle size of 100 dried gastro spheres from each batch was 
measured by the optical microscopic method for average particle 
size using an optical microscope. The ocular micrometer was 
previously calibrated by stage micrometer. 
Fourier transforms infrared spectroscopy 
Fourier transform infrared spectra were obtained using Shimadzu 
FTIR-8400S spectrometer, Japan. Samples of carvedilol, physical 
mixtures and optimized formulation of microsphere were taken for 
the study. The scanning range was 500 to 4000 cm-1and the 
resolution was 4 cm-1
Powder X-ray diffraction (PXRD) 
. 
PXRD patterns were recorded using BRUCKER D2 PHASER A26-X1 
ABOB2A, fitted with a copper target, a voltage of 40 kV, and a 
current of 30mA. The scanning rate was 1 °/min over a 2 θ range of 
1-50 °. PXRD patterns were traced for carvedilol, physical mixture, 
and formulation. The samples were slightly ground and packed into 
the aluminum sample container. 
Differential scanning calorimetric (DSC) 
DSC analysis of the samples was carried out on a Perkin-Elmer DSC7, 
USA. Samples (6.5-10 mg) were heated under nitrogen atmosphere 
on an aluminum pan at a heating rate of 10 °C/min over the 
temperature range of 5 and 300 °C. DSC analysis was carried out 
under nitrogen gas flow of 20 lb/in2. 
Scanning electron microscopy and morphology 
characterization (SEM) 
The surface morphology of the gastro spheres was studied by 
scanning electron microscopy Scanning Electron Microscope JSM 
6330 JEOL (Japan). Acceleration voltage set at 3Kv at Magnification 
level 65x, 500x, 2000x, 5000 x. The samples were then randomly 
scanned and microphotographs were taken on different 
magnification. Then morphological characteristics of gastro spheres 
were determined from a photograph of SEM. 
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In vitro mucoadhesive test 
The mucoadhesive property of optimized carvedilol gastro spheres 
was evaluated by ex vivo wash-off method. Freshly excised pieces of 
goat intestinal mucosa (2 cm × 2 cm) (collected from the 
slaughterhouse) were mounted in the glass slide (7.5 cm × 2.5 cm) 
using thread. About 20 gastro spheres were spread onto the wet tissue 
specimen, and the prepared slide was hung onto a groove of the 
disintegration test apparatus. The tissue specimen was given a regular 
up and down movement in a vessel containing 900 ml of 0.1 N HCl at 
37+/-0.5 ◦C. After regular time intervals, the machine was stopped 
and the number of gastro spheres still adhering to the tissue was 
counted [8].  
In vitro drug release study 
The release of carvedilol from various gastrosphere was tested using 
a dissolution apparatus USP type II. The dissolution rates were 
measured at 37+/-1 ◦C under 50 rpm speed. Accurately weighed 
quantities of gastro spheres containing carvedilol equivalent to 50 
mg were added to 900 ml of 0.1 N HCl. 5 ml of aliquots was collected 
at regular time intervals, and the same amount of a fresh dissolution 
mediums was replaced into the dissolution vessel to maintain the 
sink condition throughout the experiment. The collected aliquots 
were filtered and suitably diluted to determine the absorbance using 
a UV–vis spectrophotometer (Lab India) at 280 nm against an 
appropriate blank.  
RESULTS AND DISCUSSION 
Factorial design with surface plots & optimization of process 
variables 
The influences of factors on investigating responses were elucidated 
by response surface methodology. Response surface methodology is a 
widely used approach for the development and optimization of drug 
delivery formulations, which has been utilized by the formulators to 
investigate the combined effect of investigating factors on the desired 
responses. The three-dimensional response surface graphs are very 
useful in learning about the main effects and interaction effects of the 
independent variables. The three-dimensional response surface plots 
(fig. 1, 2) were presented to estimate the effects of the independent 
variables (factors) on each response investigated.  
X1= Sodium alginate  
X2= sodium carboxymethyl cellulose  
An interactive statistical second-order complete model equation was 
generated to evaluate the selected response which is as follows:  
Y=b0+b1X1+b2X2+b12X1X2+b11X12+b22X22 
Where Y is the predicted response, b0 is the arithmetic mean response 
of 9 runs and b1is the estimated coefficient for the factor X1. The main 
effects (X1 and X2) represent the average result of changing one factor 
at a time from its low value to its high value. The interaction (X1X2) 
shows how drug content of formulation as well as encapsulation 
efficiency changes when two factors are simultaneously changed, and 
the exponential terms (and) represent curvature. The coefficients 
corresponding linear effects (b1 and b2), interaction (b12) and the 
quadratic effects (b11 and b12) were determined from the results from 
the experiment (STAT-EASE, design expert, 7.0.0) [8, 10]
 
Fig. 1: Response surface plot for drug entrapment efficiency of 




Fig. 2: Response surface plot for %drug release of carvedilol 
gastro spheres 
 
Drug entrapment efficiency 
The encapsulation efficiency determines the percentage of 
encapsulated drug with respect to the total drug introduced into the 
polymer solution. Effect of polymer content on encapsulation 
efficiency was studied.  
The encapsulation efficiency in 0.1 N HCl was in the range of 37.65% 
to 52.88% respectively (table 3). It is evident that with the increase 
in the polymer concentration encapsulation efficiency also 
increased. This may be due to the increase in viscosity of the 
polymer solutions with the increase in the concentration of polymer. 
This might have prevented drug discharge from the prepared 
microsphere to the cross-linking solution [9, 14]. Encapsulation 
efficiencies from the 9 batch experiments were used to generate 
predictor equations for carvedilol gastro spheres with independent 




Table 3: Drug entrapment efficiency and particle size analysis*of gastro spheres 
Formulation %DEE Particle Size(µm) 
F1 37.65±0.158 730±0.33 
F2 40.45±0.102 738±0.88 
F3 44.61±0.186 740±0.66 
F4 41.69±0.156 762±0.66 
F5 45.30±0.093 778±1.52 
F6 48.76±0.093 826±1.20 
F7 45.59±0.098 854±0.33 
F8 49.63±0.165 878±2.66 
F9 52.88±0.241 902±0.88 
*Indicates±SD (n = 3), SD: Standard deviation, µm: micro meter, DEE: Drug Entrapment efficiency. 
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The fitted model for drug entrapment efficiency is a quadratic 
model & expressed as:  
Final equation in terms of coded factors 
Drug Entrapment Efficiency =+45.17+3.55 * SA+4.23 * NaCMC  
[R2 =0.9974; Adjusted R2 =0.9966; Predicted R2 =0.9940; F= 
1167.58;P<0.05]  
From the Response Surface plot for drug entrapment efficiency (fig. 
1) it is observed that the change in concentration of sodium alginate 
and sodium carboxymethyl cellulose affects drug entrapment 
efficiency. It was observed that with an increase in the concentration 
of sodium alginate drug entrapment efficiency increases, however, 
increase in the concentration of sodium carboxymethyl cellulose 
drug entrapment efficiency decreases. From the statistical second-
order complete model equation, it can be concluded that among the 
polymers used sodium carboxymethyl cellulose had a more 
profound effect on drug entrapment efficiency as compared to 
sodium alginate. All the formulations were spherical in particle 
shape with a smooth surface. The mean particle size of gastro 
spheres ranged from 730 to 902μm (table 3), which indicate 
narrower particle size distribution. It was also noted that increasing 
the drug to the polymer ratio increased the particle size this might 
be due to increased viscosity of feed solution, which influences the 
interaction between dispersing phase and dispersion medium who 
affects the size distribution of particle [16]
FT-IR spectroscopy 
.  
FTIR spectra of Carvedilol and its combination with excipients are 
shown in fig. 3. An IR spectrum of pure Carvedilol showed characteristic 
peaks at 3352.05 cm-1(O-H and N-H stretching vibration peaks), 
2938.40 cm-1(C-H stretching vibrations), 1596.88 cm-1(N-H bending 
vibrations) and 1241.16 cm-1(O-H bending and C-O stretching 
vibrations). These peaks can be considered as characteristic peaks of 
Carvedilol and were not affected and prominently observed in IR spectra 
of Carvedilol along with excipients as shown in (fig. 3) it indicates no 
interaction between Carvedilol and excipients. 
 
 
Fig. 3: IR Spectras of a) Carvedilol b) Carvedilol+SCMC c) 
Carvedilol+SCMC+NA. Alginate d) Formulation F5 
 
The IR spectrum of the formulation showed that there was no 
significant evidence for interaction between drug and the polymer. 
Peaks of the drug were observed in formulations. 
XRD 
Carvedilol has crystalline characteristics, which are represented by 
peaks in X-ray diffraction, and the most evident peaks appear at 2θ = 
12.67, 13.18, 19.60 and 22.14(fig. 4). These peaks were not observed 
in the Carvedilol loaded gastro spheres. This indicates that drug 
particles are dispersed at the molecular level in the polymer 
matrices since no indication about the crystalline nature of the drugs 




Fig. 4: X-Ray diffraction Spectras of A) Carvedilol B) 




DSC is a fast and reliable method for understanding polymorphic 
transition when screening drugs and excipients for compatibility, 
obtaining information about possible interactions. The results of 
DSC studies are shown in fig. 5. DSC thermogram showed an 
endothermic peak of Carvedilol at 87 ° C, which corresponds to its 
melting point. The presence of detectable peaks of Carvedilol in a 
physical mixture is an indication of uniform mixing of excipients. 
The absence of peaks of Carvedilol loaded gastro spheres in 
formulation F5 clearly indicates that Carvedilol was dispersed 
completely in the formulation, thus modifying the gastro spheres to 




Fig. 5: DSC thermograms of A) pure carvedilol B) 
Carvedilol+SCMC C) Carvedilol+SCMC+NA. Alginate D) 
Formulation F5 
Sakhare et al. 
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The additional peak was observed due to loss of moisture (hydrate form) 
and degradation peak [14]. The absence of detectable crystalline 
domains of Carvedilol in drug loaded gastro spheres clearly indicates 
that Carvedilol encapsulated in gastro spheres is in the amorphous-
crystalline phase or in the solid state solubilized form in the polymer 
matrix.  
SEM 
The morphological analysis of the mucoadhesive gastro spheres was 
studied by Scanning Electron Microscopy (SEM). SEM photo micro-
graphs of optimized formulation (F5) gastro spheres were rough 
spherical and shows few pore at the surface (fig. 6). Particulate 
matters of the drug and polymer were seen at the surface of the gastro 
spheres, indicating uniform distribution of the drug in the polymeric 
network [10]. The SEM photographs indicated that the gastro spheres 




Fig. 6: Scanning electron photograph of drug loaded 
Gastrosphere (Magnification, X65, X500, X2000, and X5000) 
 
The spherical shape and rough texture with shrinkage were due to the 
removal of water from gastro spheres during drying. Thus the rate of 
removal of water from gastro spheres exerts an influence on the 
morphology of final product [19]. The fig. 6 shows the appearance of 
white spot on the surface of gastro spheres, when increasing the 
concentration of carvedilol. Probably those spots represent Carvedilol 
crystal precipitation on the particle surface [20].
In vitro mucoadhesive test 
  
The in vitro mucoadhesive test using goat intestinal mucosa for 
assessing mucoadhesivity of gastro spheres containing carvedilol was 
performed in 0. 1N HCl for 8 h. The percentage of gastro spheres 
adhering to the goat intestinal mucosal tissue varied from 10% to 20 
% over 8 h (fig. 7). Less mucoadhesion of gastro spheres containing 
carvedilol may be due to the reason that at lower concentration the 
polymer structure is looser and the polymer chain have more space to 
extend within the mucus, as the number of polymer chains penetrating 
in mucus is increased a strong bond, either chemical, mechanical or 
both is formed between the mucus and the polymer [8]. Amongst all 
nine batches F5 batch gives more mucoadhesive property.  
 
 
Fig. 7: In vitro mucoadhesive strength of carvedilol gastro spheres  
N=3, error bars omitted for clarity of the fig 
In vitro drug release study 
Gastro spheres were subjected to in vitro release using basket type 
dissolution apparatus in 900 ml of 0.1N HCl medium. The results of 
the in vitro drug release studies are shown in fig. 8. The release rate 
was found to be decreased in accordance with the increase in the 
ratio of polymer used. Carvedilol release from the gastro spheres 
was studied in gastric buffer 0.1N HCl for 12 h. In the case of gastro 
spheres containing higher polymer contents, the more hydrophilic 
property of the polymers could probably bind better with water to 
form a viscous gel structure, which might block the pores on the 
surface of gastro sphere and could delay the drug release [8]. Among 
all the fabricated formulation, F5 was chosen as an ideal formulation 
showing an extended drug release over a period of 12h (88.55%) 
with the acceptable mucoadhesive property. The drug release from 
the 9 batches was used to generate predictor equations for Carvedilol 
gastro spheres with independent variables as sodium alginate 




Fig. 8: In vitro drug release from various Carvedilol gastro 
spheres prepared through ionotropic gelation [mean+/-SD, n = 3] 
 
Final equation in terms of coded factors 
Drug Release =+77.14+2.17 * SA+4.26 * NaCMC 
[R2 =0.7096;Adjusted R2 =0.6128;Predicted R2 =0.2562;F= 
7.33;P<0.05] 
From the Response Surface plot for drug entrapment efficiency (fig. 
2) it was observed that the change in concentration of sodium 
alginate and sodium carboxyl methyl cellulose affected the drug 
release. It was observed that increase in the concentration of sodium 
alginate increases the drug release up to the certain extent the 
further increase in the concentration of sodium alginate retards the 
drug release values. However, a decrease in drug release values with 
the increasing SCMC amount (X2) is indicated by the three-
dimensional response surface graph relating drug release (fig. 2). 
Surface response plot indicates that sodium alginate concentration 
at the optimum level 400 mg yielded gastro spheres with the highest 
drug release with SCMC concentration at 200 mg. Hence the 
Optimized Batch was found to be F5 with the optimum level of 
sodium Alginate and SCMC. From the statistical second-order 
complete model equation, it can be concluded that among the 
polymers used sodium carboxyl methyl cellulose has a more 
profound effect on drug release as compared to sodium alginate.
Release kinetics 
  
The in vitro drug release data from the various mucoadhesive gastro 
spheres containing carvedilol were evaluated kinetically using 
various mathematical models like zero order, first order, Higuchi, 
and Korsmeyer–Peppas model [8, 18]. When respective correlation 
coefficients of these gastro spheres were compared the Carvedilol 
release from these gastro spheres was found to follow the zero-
order model (R2 = 0.956–0.996). In addition, Korsmeyer–Peppas 
model (R2 = 0.931–0.980) was found to be closer to the best fit zero 
order model. The best fit of the zero order model indicated that the 
drug release from these gastro spheres followed the sustained-
Sakhare et al. 
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release pattern. The values of the release exponent (n) determined 
from in vitro drug release data of various Carvedilol gastro sphere 
F1, F2,F3, F4, F5, F6, F7and F9 follows the analomus non fickian 
drug release pattern (0.667-0.851) i.e. the rates of solvent 
penetration and drug release are in the same range. And F8 
indicating the drug release from these gastro spheres followed the 
case II transport mechanism (0.906). The mechanisms controlled by 
swelling and relaxation of polymer in the matrix.  
CONCLUSION 
From the present study, it was concluded that mucoadhesive gastro 
sphere of Carvedilol can be prepared using the ionotropic gelation 
method. The preparation process was simple, reliable, and 
inexpensive. 32 full factorial designs are suitable to study the effect 
of process variables on formulation characteristics by applying 
statistical analysis. From the study, we successfully developed 
microparticulate drug delivery system of Carvedilol by using 
mucoadhesive polymers like Na CMC and rate retardant sodium 
alginate polymer. Further, in vivo investigation is required to 
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